Effects of soy on metabolic biomarkers of cardiovascular disease in elderly women with metabolic syndrome

Archives of Iranian Medicine

Volumn 15, Issue 8, 2012, Pages 462-468

  Bakhtiary, Afsaneh ^a   Yassin, Zaitun ^b   Hanachi, Parichehr ^c   Rahmat, Asmah ^b   Ahmad, Zaiton ^b   Jalali, Farzad ^a  

^a BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^c ALZAHRA UNIVERSITY   (Iran)

Author keywords

Aging; Dyslipidemia; Inflammatory factor; Metabolic syndrome; Soy foods

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SOYBEAN PROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; FLATULENCE; HUMAN; IRAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; RANDOMIZED CONTROLLED TRIAL; RURAL HEALTH CARE; SOY NUT; SOYBEAN;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL; FEMALE; HUMANS; LIPOPROTEINS; METABOLIC SYNDROME X; MIDDLE AGED; SOYBEAN PROTEINS; TRIGLYCERIDES;

EID: 84864766506     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Kaaja RJ. Metabolic syndrome and the menopause. Menopause Int. 2008; 14: 21-25.
2. Handelsmn Y. Metabolic syndrome pathophysiology and clinical presentation. Toxicol Pathol. 2008; 37: 18-20.
3. Odrowaz-Sypniewska G. Markers of pro-inflammatory and prothrombotic state in the diagnosis of metabolic syndrome. Adv Med Sci. 2007; 52: 246-250.
4. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome: a new worldwide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006; 23: 469-480.
5. Eshtiaghi R, Esteghamati A, Nakhjavani M. Menopause is an independent predictor of metabolic syndrome in Iranian women. Maturitas. 2010; 65: 262-266.
6. Lutsey PL, Steffen LM, Stevens J. Dietary intake and the development of the metabolic syndrome: The Atherosclerosis Risk in Communities study. Circulation. 2008; 117: 754-761.
7. Feldeisen SE, Tucker KL. Nutritional strategies in the prevention and treatment of metabolic syndrome. Appl Physiol Nutr Metab. 2007; 32: 46-60.
8. Djousse L, Padilla H, Nelson TL. Diet and metabolic syndrome. Endocr Metab Immune Disord Drug Targets. 2010; 10: 124-137.
9. McVeigh BL, Dillingham BL, Lampe JW. Effect of soy protein varying in isoflavone content on serum lipids in healthy young men. Am J Clin Nutr. 2006; 83: 244-251.
10. Hall WL, Vafeiadou K, Hallund J. Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production. Am J Clin Nutr. 2006; 83: 592-600.
11. Sacks FM, Lichtenstein A, Van Horn L. Soy protein, isoflavones, and cardiovascular health: An American Heart Association science advisory for professionals from the Nutrition Committee. Circulation. 2006; 113: 1034-1044.
12. Sakai T, Kogiso M. Soy isoflavone and immunity. J Med Invest. 2008; 55: 167-173.
13. Hanachi P, Golkho S. Assessment of soy phytoestrogens and exercise on lipid profiles and menopause symptoms in menopausal women. J Biol Sci. 2008; 8: 789-793.
14. Moutsatsou, P. The spectrum of phytoestrogens in nature: our knowledge is expanding. Hormones. 2007; 6: 173-193.
15. Wang CC, Prasain JK, Barnes S. Review of the methods used in the determination of phytoestrogens. J Chromatogr B, Analytical technol Biomed Life Sci. 2002; 777: 3-28.
16. Welty FK, Lee KS, Lew NS. Effect of soy nuts on blood pressure and lipid levels in hypertensive, prehypertensive, and normotensive postmenopausal women. Arch Intern Med. 2007; 167: 1060-1067.
17. Matthan NR, Jalbert SM, Ausman LM. Effect of soy protein from differently processed products on cardiovascular disease risk factors and vascular endothelial function in hypercholesterolemic subjects. Am J Clin Nutr. 2007; 85: 960-966.
18. Chen ST, Chen JR, Yang CS. Effect of soya protein on serum lipid profile and lipoprotein concentrations in patients undergoing hypercholesterolaemic haemodialysis. Br J Nutr. 2006; 95: 366-371.
19. Pipe EA, Gobert CP, Capes SE. Soy protein reduces serum LDL cholesterol and the LDL cholesterol: HDL cholesterol and apolipoprotein B: apolipoprotein A-I ratios in adults with type 2 diabetes. J Nutr. 2009; 139: 1700-1706.
20. Zhan S, Ho SC. Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr. 2005; 81: 397-408.
21. Duranti M, Lovati MR, Dani V. The alpha' subunit from soybean 7S globulin lowers plasma lipids and upregulates liver beta-VLDL receptors in rats fed a hypercholesterolemic diet. J Nutr. 2004; 134: 1334-1339.
22. Moriyama T, Kishimoto K, Nagai K. Soybean beta-conglycinin diet suppresses serum triglyceride levels in normal and genetically obese mice by induction of beta-oxidation, downregulation of fatty acid synthase, and inhibition of triglyceride absorption. Biosci Biotechnol Biochem. 2004; 68: 352-359.
23. Tian L, Fu M. The relationship between high density lipoprotein subclass profile and plasma lipids concentrations. Lipids Health Disease. 2010; 9: 118.
24. Hermansen K, Sondergaard M, Hoie L. Beneficial effects of a soybased dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes Care. 2001; 24: 228-233.
25. Borodin EA, Menshikova IG, Dorovskikh VA. Effects of two-month consumption of 30 g a day of soy protein isolate or skimmed curd protein on blood lipid concentration in Russian adults with hyperlipidemia. J Nutr Sci Vitaminol. 2009; 55: 492-497.
26. Galisteo M, Duarte J, Zarzuelo A. Effects of dietary fibres on disturbances clustered in the metabolic syndrome. J Nutr Biochem. 2008; 19: 71-84.
27. Brown L, Rosner B, Willett WW. Cholesterol-lowering effects of dietary fibre: a meta-analysis. Am J Clin Nutr.1999; 69: 30-42.
28. Beavers KM, Jonnalagadda SS, Messina MJ. Soy consumption, adhesion molecules, and pro-inflammatory cytokines: a brief review of the literature. Nutr Rev. 2009; 67: 213-221.
29. Jenkins DJ, Kendall CW, Jackson CJ. Effects of high- and low-isoflavone soy foods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr. 2002; 76: 365-372.
30. Blum A, Lang N, Peleg A. Effects of oral soy protein on markers of inflammation in postmenopausal women with mild hypercholesterolemia. Am Heart J. 2003; 145: e7.
31. Hanson LN, Engelman HM, Alekel DL. Effects of soy isoflavones and phytate on homocysteine, C-reactive protein, and iron status in postmenopausal women. Am J Clin Nutr. 2006; 84: 774-780.
32. Nikander E, Metsa-Heikkila M, Tiitinen A. Evidence of a lack of effect of a phytoestrogen regimen on the levels of C-reactive protein, E-selectin, and nitrate in postmenopausal women. J Clin Endocrino Metab. 2003; 88: 5180-5185.
33. Christie DR, Grant J, Darnell BE. Metabolic effects of soy supplementation in postmenopausal Caucasian and African American women: a randomized, placebo-controlled trial. Am J Obstet Gynecol. 2010; 203: 153.e1-153.e9.
34. Li Z, Hong K, Saltsman P. Long-term efficacy of soy-based meal replacements vs. an individualized diet plan in obese type II DM patients: relative effects on weight loss, metabolic parameters, and C-reactive protein. Eur J Clinl Nutr.2005; 59: 411-418.
35. Azadbakht L, Atabak S, Esmaillzadeh A. Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial. Diabetes Care. 2008; 31: 648-654.
36. Helferich WG, Andrade JE, Hoagland MS. 2008. Phytoestrogens and breast cancer: a complex story. Inflammopharmacology. 2008; 16: 219-226.
37. Ma J, Xu A, Jia C, Liu L, Fu Z, Dong J, et al. Associations of fibrinogen with metabolic syndrome in rural Chinese population. J Atheroscler Thromb. 2010; 17: 486-492.
38. Kondo K, Suzuki Y, Ikeda Y. Genistein, an isoflavone included in soy, inhibits thrombotic vessel occlusion in the mouse femoral artery and in vitro platelet aggregation. Eur J Pharmacol. 2002; 455: 53-57.
39. Dent SB, Peterson CT, Brace LD. Soy protein intake by perimenopausal women does not affect circulating lipids and lipoproteins or coagulation and fibrinolytic factors. J Nutr. 2001; 131: 2280-2287.
40. Yang G, Shu XO, Jin F. Longitudinal study of soy food intake and blood pressure among middle-aged and elderly Chinese women. Am J Clin Nutr. 2005; 81: 1012-1017.